BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35892885)

  • 1. Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.
    Suh YG; Noh JM; Lee DY; Kim TH; Bayasgalan U; Pyo H; Moon SH
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Comparisons between Proton Beam Therapy and Modern Photon Radiation Techniques for Stage I Non-Small Cell Lung Cancer According to Tumor Location.
    Bayasgalan U; Moon SH; Kim TH; Kim TY; Lee SH; Suh YG
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
    Boyce-Fappiano D; Nguyen QN; Chapman BV; Allen PK; Gjyshi O; Pezzi TA; De B; Gomez D; Lin SH; Chang JY; Liao Z; Lee P; Gandhi SJ
    Clin Lung Cancer; 2021 Sep; 22(5):e745-e755. PubMed ID: 33707003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer.
    Seo SH; Pyo H; Ahn YC; Oh D; Yang K; Kim N; Sun JM; Park S; Jung HA; Lee SH; Ahn JS; Ahn MJ; Noh JM
    Radiat Oncol J; 2023 Dec; 41(4):274-282. PubMed ID: 38185932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
    Hsieh RC; Lee CH; Huang HC; Wu SW; Chou CY; Hung SP; Lee CW; Krishnan S; Venkatesulu BP; Lee JC; Chou YC; Chan KM; Lin PT; Lee WC; Lin CC; Lin SY; Hong JH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):712-724. PubMed ID: 37778426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
    Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.
    Chi A; Chen H; Wen S; Yan H; Liao Z
    Radiother Oncol; 2017 Jun; 123(3):346-354. PubMed ID: 28545956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.
    Bayasgalan U; Moon SH; Jeong JH; Kim TH; Cho KH; Suh YG
    Radiat Oncol; 2021 Aug; 16(1):155. PubMed ID: 34407855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Mori Y; Baba K; Nakazawa K; Shiozawa T; Sekine I; Maruo K; Okumura T; Sakurai H
    J Radiat Res; 2023 Mar; 64(2):438-447. PubMed ID: 36592478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photon
    Suh YG; Bayasgalan U; Kim HT; Lee JM; Kim MS; Lee Y; Lee DY; Lee SU; Kim TH; Moon SH
    Front Oncol; 2021; 11():699172. PubMed ID: 34235087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors.
    Lischalk JW; Chen H; Repka MC; Campbell LD; Obayomi-Davies O; Kataria S; Kole TP; Rudra S; Collins BT
    Adv Radiat Oncol; 2018; 3(3):447-457. PubMed ID: 30202812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
    Yang K; Noh JM; Park HY; Yoo H; Shin SH; Pyo H
    Front Oncol; 2024; 14():1296172. PubMed ID: 38444671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.